Melnes Torunn, Bogsrud Martin P, Christensen Jacob J, Rundblad Amanda, Retterstøl Kjetil, Narverud Ingunn, Aukrust Pål, Halvorsen Bente, Ulven Stine M, Holven Kirsten B
Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Unit for Cardiac and Cardiovascular Genetics, Department of Medical Genetics, Oslo University Hospital Ullevål, Norway.
Am J Prev Cardiol. 2025 Mar 29;22:100986. doi: 10.1016/j.ajpc.2025.100986. eCollection 2025 Jun.
Familial hypercholesterolemia (FH) is a genetic disorder characterized by elevated low-density lipoprotein cholesterol (LDL-C) and increased risk of premature coronary heart disease (CHD). While current LDL-C levels usually guides therapy, the cumulative exposure to LDL-C (the LDL-C burden) is suggested to offer a more precise estimate of cardiovascular risk in people with FH. Therefore, using real-world data, this study aimed to estimate the LDL-C burden at different ages in elderly FH patients with and without CHD, and to assess the LDL-C burden at CHD onset.
Data was retrospectively collected from the medical records of elderly (>60 years) FH patients at the Lipid Clinic in Oslo. The LDL-C burden (mM-years) was estimated based on repeated LDL-C measurements and information on lipid-lowering medication. Time-weighted average (TWA) LDL-C was calculated as LDL-C burden divided by years.
We included 112 FH patients, of which 55 (49 %) had experienced at least one CHD-event, and 58 (52 %) were females. Median age at first and last visit were 50 years and 68 years, respectively, with a median of 9 (range; 2-14) available LDL-C measurements. Subjects with CHD had higher LDL-C burden at all ages tested (45, 50 and 60 years) compared with the non-CHD group ( < 0.01, also after adjusting for sex), and had higher TWA LDL-C before treatment at the Lipid Clinic ( = 0.004), but not during follow-up ( = 0.6). There were no sex differences in LDL-C burden at all ages tested, also after adjusting for CHD ( > 0.1). However, women had higher TWA LDL-C during follow-up at the Lipid Clinic ( = 0.01). Median LDL-C burden at CHD onset was 352 mM-years; numerically lower in women than in men (320 vs. 357 mM-years, respectively. = 0.1).
Elderly FH patients with CHD had higher estimated LDL-C burden compared with FH patients without CHD, due to higher burden , highlighting the importance of earlydetection and treatment.
家族性高胆固醇血症(FH)是一种遗传性疾病,其特征为低密度脂蛋白胆固醇(LDL-C)升高以及早发冠心病(CHD)风险增加。虽然目前LDL-C水平通常指导治疗,但累积LDL-C暴露量(LDL-C负担)被认为能更精确地估计FH患者的心血管风险。因此,本研究利用真实世界数据,旨在估计有和没有CHD的老年FH患者在不同年龄的LDL-C负担,并评估CHD发病时的LDL-C负担。
回顾性收集奥斯陆脂质门诊老年(>60岁)FH患者的病历数据。基于重复的LDL-C测量值和降脂药物信息估计LDL-C负担(mmol·年)。时间加权平均(TWA)LDL-C计算为LDL-C负担除以年数。
我们纳入了112例FH患者,其中55例(49%)经历过至少一次CHD事件,58例(52%)为女性。首次和末次就诊的中位年龄分别为50岁和68岁,中位有9次(范围:2 - 14次)可用的LDL-C测量值。与无CHD组相比,CHD患者在所有测试年龄(45、50和60岁)的LDL-C负担更高(P<0.01,调整性别后也是如此),且在脂质门诊治疗前的TWA LDL-C更高(P = 0.004),但随访期间无差异(P = 0.6)。在所有测试年龄,调整CHD后LDL-C负担也无性别差异(P>0.1)。然而,女性在脂质门诊随访期间的TWA LDL-C更高(P = 0.01)。CHD发病时的LDL-C负担中位数为352 mmol·年;女性数值上低于男性(分别为320和357 mmol·年,P = 0.1)。
与无CHD的FH患者相比,有CHD的老年FH患者估计的LDL-C负担更高,这归因于更高的负担,凸显了早期检测和治疗的重要性。